Abstract
Intravascular hemolysis is an uncommon but serious risk in those who undergo prosthetic heart valve placement, which has been reduced by using bioprosthetic valves. Throughout the multicenter Investigational Device Exemption (IDE) Melody valve trial, there were no documented cases of post-
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
